Inventor · disambiguated record
Laurence Jn Cooper
Also filed as: COOPER LAURENCE · COOPER LAURENCE J N · COOPER LAURENCE J NEIL · COOPER LAURENCE JN
9 granted patents·7 pending applications·235 citations·filing 2012–2021
88Inventor score
Top patents by PatentIndex Score
16 records- 0193US9701758B2Anti-CD19 scFv (FMC63) polypeptideUNIV TEXAS·Filed 2014·Granted Jul 11, 2017·73 cites·6 claims
- 0293US9629877B2Human application of engineered chimeric antigen receptor (CAR) T-cellsUNIV TEXAS·Filed 2014·Granted Apr 25, 2017·131 cites·31 claims
- 0388US10570186B2Chimeric antigen receptors (CAR) to selectively target protein complexesUNIV TEXAS·Filed 2015·Granted Feb 25, 2020·9 cites·18 claims
- 0487US11344577B2Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLAUNIV TEXAS·Filed 2019·Granted May 31, 2022·3 cites·20 claims
- 0587US10391126B2CAR+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLAUNIV TEXAS·Filed 2012·Granted Aug 27, 2019·12 cites·14 claims
- 0687US9907820B2Polyclonal gamma delta T cells for immunotherapyUNIV TEXAS·Filed 2014·Granted Mar 6, 2018·7 cites·7 claims
- 0772US11786582B2Human application of engineered chimeric antigen receptor (CAR) T-cellsUNIV TEXAS·Filed 2021·Granted Oct 17, 2023·0 cites·20 claims
- 0862US11548945B2T-cell receptor (TCR)-binding antibodies and uses thereofUNIV TEXAS·Filed 2020·Granted Jan 10, 2023·0 cites·14 claims
- 0961US2020085929A1Human application of engineered chimeric antigen receptor (car) t-cellsUNIV TEXAS·Filed 2019·Application pending·0 cites
- 1058US2020017882A1Engineering of humanized car t-cell and platelets by genetic complementationRECOMBINETICS INC·Filed 2019·Application pending·0 cites
- 1157US2017152526A1Engineering of humanized car t-cell and platelets by genetic complementationRECOMBINETICS INC·Filed 2016·Application pending·0 cites
- 1254US2017224798A1Human application of engineered chimeric antigen receptor (car) t-cellsUNIV TEXAS·Filed 2017·Application pending·0 cites
- 1353US2018265595A1ANTI-CD19 scFv (FMC63) POLYPEPTIDE AND USES THEREOFUNIV TEXAS·Filed 2018·Application pending·0 cites
- 1453US2017342164A1ANTI-CD19 scFv (FMC63) POLYPEPTIDEUNIV TEXAS·Filed 2017·Application pending·0 cites
- 1552US10808230B2Selection methods for genetically-modified T cellsUNIV TEXAS·Filed 2016·Granted Oct 20, 2020·0 cites·19 claims
- 1636US2017044500A1Application of induced pluripotent stem cells to generate adoptive cell therapy productsUNIV TEXAS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Laurence Jn Cooper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →